中国美容医学
中國美容醫學
중국미용의학
CHINESE JOURNAL OF AESTHETIC MEDICINE
2014年
24期
2099-2101
,共3页
黎艳%黄守春%熊想莲%黄桂芳%肖榕婵
黎豔%黃守春%熊想蓮%黃桂芳%肖榕嬋
려염%황수춘%웅상련%황계방%초용선
桥式交叉皮瓣%患者参与型护理模式%护理
橋式交扠皮瓣%患者參與型護理模式%護理
교식교차피판%환자삼여형호리모식%호리
cross bridge flap%nursing model of patient- participation%nursing
目的:探讨患者参与型护理模式对吻合血管桥式交叉皮瓣的临床疗效影响。方法:将2012年4月~2014年6月吻合血管桥式交叉皮瓣术式患者80例随机分为2组,观察组采取患者参与型护理模式应用于术前、术后的护理,对照组行一般护理模式护理,比较两种护理模式在吻合血管桥式交叉皮瓣术后患者的舒适度和临床疗效。结果:观察组术后第1天、第3天、1周、皮瓣断蒂后第2天患者的舒适度和皮瓣成活率、断蒂后功能恢复情况明显优胜于对照组,差别有统计学意义(<0.05)。结论:总结出患者参与型护理模式是一个能提高吻合血管桥式交叉皮瓣术后患者舒适度和临床疗效的国内可行性护理模式。
目的:探討患者參與型護理模式對吻閤血管橋式交扠皮瓣的臨床療效影響。方法:將2012年4月~2014年6月吻閤血管橋式交扠皮瓣術式患者80例隨機分為2組,觀察組採取患者參與型護理模式應用于術前、術後的護理,對照組行一般護理模式護理,比較兩種護理模式在吻閤血管橋式交扠皮瓣術後患者的舒適度和臨床療效。結果:觀察組術後第1天、第3天、1週、皮瓣斷蒂後第2天患者的舒適度和皮瓣成活率、斷蒂後功能恢複情況明顯優勝于對照組,差彆有統計學意義(<0.05)。結論:總結齣患者參與型護理模式是一箇能提高吻閤血管橋式交扠皮瓣術後患者舒適度和臨床療效的國內可行性護理模式。
목적:탐토환자삼여형호리모식대문합혈관교식교차피판적림상료효영향。방법:장2012년4월~2014년6월문합혈관교식교차피판술식환자80례수궤분위2조,관찰조채취환자삼여형호리모식응용우술전、술후적호리,대조조행일반호리모식호리,비교량충호리모식재문합혈관교식교차피판술후환자적서괄도화림상료효。결과:관찰조술후제1천、제3천、1주、피판단체후제2천환자적서괄도화피판성활솔、단체후공능회복정황명현우성우대조조,차별유통계학의의(<0.05)。결론:총결출환자삼여형호리모식시일개능제고문합혈관교식교차피판술후환자서괄도화림상료효적국내가행성호리모식。
Objective To explore the clinical effect of Nursing Model of Patient- participation in cross bridge vascular anastomosis flap operation. Methods 80 patients accepted cross bridge vascular anastomosis flap operation from April 2012 to June 2014 ,were randomly divided into 2 groups, 40 cases were received Nursing Model of Patient- participation, the control group of 40 cases received general nursing model ,the clinical effect was compared after operation. <0.05 was considered statistically significant difference. Results The survival rate of the flap and functional recovery of observation group was significantly superior to the control group ( <0.05) in the comfort of after one day, three days and one week after the operation. Conclusion Nursing Model of Patient- participation can improve the comfort and clinical effect after the cross bridge vascular anastomosis flap operation, This nursing model could thought a feasible nursing model in China.